
Allosteric Bioscience Licenses Sarcopenia Treatment Tech from Johns Hopkins
Allosteric Bioscience, Inc. Partners with Johns Hopkins to Combat Sarcopenia Addressing Sarcopenia: A Growing Global Concern Allosteric Bioscience, Inc. is tackling this issue head-on by announcing the licensing of a groundbreaking technology from Johns Hopkins University aimed at treating and…